Skip to content
PubMed This is a summary of 44 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 44 referenced papers

Top Authors

Helen K. Reddel
Woolcock Institute of Medical Research
Louis‐Philippe Boulet
Université Laval
Richard Beasley
Victoria University of Wellington
Eric D. Bateman
University of Cape Town
Paul M. O’Byrne
St. Joseph Hospital
J. Mark FitzGerald
University of British Columbia
Ian Pavord
University of Oxford
Jonathan Corren
University of California, Los Angeles
Mitchell Goldman
AstraZeneca (Japan)
Mario Castro
University of Kansas Medical Center

Top Institutions

Ranked by publications Top 10 institutions
05

Medical Research Institute of New Zealand

Wellington, New Zealand

26 papers

References

References (44)
  1. 1

    Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype.

    Konstantellou E, Papaioannou AI, Loukides S, et al.

    Respiratory medicine 2015; (109(11)):1404-9.

    PMID: 26412805
  2. 2

    Reversible airway obstruction in cystic fibrosis: Common, but not associated with characteristics of asthma.

    Levine H, Cohen-Cymberknoh M, Klein N, et al.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2016; (15(5)):652-9.

    PMID: 26826913
  3. 3

    [Value of Fractional Exhaled Nitric Oxide after Using a Beta-2 Bronchodilator in the Differential Diagnosis of Bronchial Asthma and Chronic Obstructive Pulmonary Disease].

    Ura M, Tanaka H, Takahashi K, et al.

    Rinsho byori. The Japanese journal of clinical pathology 2016; (64(2)):127-32.

    PMID: 27311275
  4. 4

    Clinical associations in the diagnosis of vocal cord dysfunction.

    Li RC, Singh U, Windom HP, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2016; (117(4)):354-358 doi:10.1016/j.anai.2016.08.002.

    PMID: 27590638
  5. 5

    Biological therapies for eosinophilic asthma.

    Patel SS, Casale TB, Cardet JC

    Expert opinion on biological therapy 2018; (18(7)):747-754 doi:10.1080/14712598.2018.1492540.

    PMID: 29938543
  6. 6

    Values of fractional exhaled nitric oxide for cough-variant asthma in children with chronic cough.

    Zhou J, Zhao X, Zhang X, et al.

    Journal of thoracic disease 2018; (10(12)):6616-6623 doi:10.21037/jtd.2018.11.137.

    PMID: 30746207
  7. 7

    Approaches to Asthma Diagnosis in Children and Adults.

    Saglani S, Menzie-Gow AN

    Frontiers in pediatrics 2019; (7()):148 doi:10.3389/fped.2019.00148.

    PMID: 31058123
  8. 8

    GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents.

    Reddel HK, FitzGerald JM, Bateman ED, et al.

    The European respiratory journal 2019; (53(6)) doi:10.1183/13993003.01046-2019.

    PMID: 31249014
  9. 9

    Occupational asthma.

    Cormier M, Lemière C

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2020; (24(1)):8-21 doi:10.5588/ijtld.19.0301.

    PMID: 32005302
  10. 10

    Performance Characteristics of Spirometry With Negative Bronchodilator Response and Methacholine Challenge Testing and Implications for Asthma Diagnosis.

    Selvanathan J, Aaron SD, Sykes JR, et al.

    Chest 2020; (158(2)):479-490 doi:10.1016/j.chest.2020.03.052.

    PMID: 32298731
  11. 11

    Are type-2 biomarkers of any help in asthma diagnosis?

    Nekoee H, Graulich E, Schleich F, et al.

    ERJ open research 2020; (6(2)) doi:10.1183/23120541.00169-2020.

    PMID: 32714964
  12. 12

    The Role of T Cells and Macrophages in Asthma Pathogenesis: A New Perspective on Mutual Crosstalk.

    Zhu X, Cui J, Yi , et al.

    Mediators of inflammation 2020; (2020()):7835284 doi:10.1155/2020/7835284.

    PMID: 32922208
  13. 13

    Bronchial asthma control degree and the temperament structure according to the Eysenck model.

    Witusik A, Mokros L, Kuna P, Pietras T

    Postepy dermatologii i alergologii 2020; (37(4)):559-565 doi:10.5114/ada.2019.83216.

    PMID: 32994779
  14. 14

    Work-related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia.

    Hoy R, Burdon J, Chen L, et al.

    Respirology (Carlton, Vic.) 2020; (25(11)):1183-1192 doi:10.1111/resp.13951.

    PMID: 33020986
  15. 15

    Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in Sweden.

    Darbà J, Ascanio M, Syk J, Alving K

    ClinicoEconomics and outcomes research : CEOR 2021; (13()):289-297 doi:10.2147/CEOR.S306389.

    PMID: 33935507
  16. 16

    Asthma phenotypes and endotypes.

    Ricciardolo FL, Bertolini F, Carriero V, Sprio AE

    Minerva medica 2021; (112(5)):547-563 doi:10.23736/S0026-4806.21.07498-X.

    PMID: 33969960
  17. 17

    Vocal Cord Dysfunction: Rapid Evidence Review.

    Malaty J, Wu V

    American family physician 2021; (104(5)):471-475.

    PMID: 34783512
  18. 18

    Asthma management in low and middle income countries: case for change.

    Mortimer K, Reddel HK, Pitrez PM, Bateman ED

    The European respiratory journal 2022; (60(3)) doi:10.1183/13993003.03179-2021.

    PMID: 35210321
  19. 19

    Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.

    Beasley R, Harrison T, Peterson S, et al.

    JAMA network open 2022; (5(3)):e220615 doi:10.1001/jamanetworkopen.2022.0615.

    PMID: 35230437
  20. 20

    Retrospective Analysis of the Starting Dose of Combined ICS/LABA for Cough-variant Asthma and Cough-predominant Asthma.

    Nakajima T, Nagano T, Nishimura Y

    In vivo (Athens, Greece) 2022; (36(2)):949-953 doi:10.21873/invivo.12785.

    PMID: 35241554
  21. 21

    Laryngoscopy diagnosis of inducible laryngeal obstruction during supervised challenge for suspected anaphylaxis.

    Stojanovic S, Zubrinich C, Sverrild A, et al.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2022; (52(8)):924-928 doi:10.1111/cea.14156.

    PMID: 35535788
  22. 22

    Targeting TSLP in Asthma.

    Parnes JR, Molfino NA, Colice G, et al.

    Journal of asthma and allergy 2022; (15()):749-765 doi:10.2147/JAA.S275039.

    PMID: 35685846
  23. 23

    Sensitivity of FEV1 and Clinical Parameters in Children With a Suspected Asthma Diagnosis.

    Fillard A, Licari A, Molinari N, et al.

    The journal of allergy and clinical immunology. In practice 2023; (11(1)):238-247 doi:10.1016/j.jaip.2022.10.011.

    PMID: 36280139
  24. 24

    Reversible Bronchial Obstruction in Primary Ciliary Dyskinesia.

    Levine H, Bar-On O, Nir V, et al.

    Journal of clinical medicine 2022; (11(22)) doi:10.3390/jcm11226791.

    PMID: 36431268
  25. 25

    Clinical, functional, and inflammatory characteristics of asthma among adults aged over 60 years old: a case-control study.

    da Silva Santos MAC, Amorim MMF, Caetano LB, et al.

    The Journal of asthma : official journal of the Association for the Care of Asthma 2023; (60(9)):1653-1660 doi:10.1080/02770903.2023.2174029.

    PMID: 36749190
  26. 26

    Relationship between meteorological and environmental factors and acute exacerbation for pediatric bronchial asthma: Comparative study before and after COVID-19 in Suzhou.

    Guo S, Chen D, Chen J, et al.

    Frontiers in public health 2023; (11()):1090474 doi:10.3389/fpubh.2023.1090474.

    PMID: 36778545
  27. 27

    Efficacy of Biologics in Severe, Uncontrolled Asthma Stratified by Blood Eosinophil Count: A Systematic Review.

    Korn S, Cook B, Simpson LJ, et al.

    Advances in therapy 2023; (40(7)):2944-2964 doi:10.1007/s12325-023-02514-0.

    PMID: 37233876
  28. 28

    Retrospective Analysis of Biologic Agent Utilization in Severe Asthma: Impact on Exacerbation Rates, Forced Expiratory Volume in the First Second (FEV1), Eosinophils, and IgE Levels.

    Khan AR, Waqar S, Rafiq Z, et al.

    Cureus 2023; (15(8)):e42818 doi:10.7759/cureus.42818.

    PMID: 37674970
  29. 29

    What is the Best Way to Diagnose Possible Asthma Patients with Negative Bronchodilator Reversibility Tests?

    Başa Akdoğan B, Koca Kalkan I, Köycü Buhari G, et al.

    Journal of asthma and allergy 2024; (17()):113-122 doi:10.2147/JAA.S437756.

    PMID: 38410137
  30. 30

    Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types.

    Panettieri R, Lugogo N, Corren J, Ambrose CS

    Journal of asthma and allergy 2024; (17()):219-236 doi:10.2147/JAA.S342391.

    PMID: 38524099
  31. 31

    Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies.

    Liu T, Woodruff PG, Zhou X

    The European respiratory journal 2024; (64(2)) doi:10.1183/13993003.00826-2023.

    PMID: 38697650
  32. 32

    Relapsing Eosinophilia in a Severe Allergic Asthma Patient on Biological Therapy.

    Raduna O, Oprescu B, Mihaicuta S, Frent S

    Journal of clinical medicine 2024; (13(12)) doi:10.3390/jcm13123402.

    PMID: 38929930
  33. 33

    Age differences in inducible laryngeal obstruction in adult populations.

    Luedders J, May S, Lyden E, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2024; (133(5)):574-580 doi:10.1016/j.anai.2024.08.005.

    PMID: 39154909
  34. 34

    Fractional Exhaled Nitric Oxide Testing for the Diagnosis and Management of Asthma: a Health Technology Assessment.

    Ontario health technology assessment series 2024; (24(5)):1-225.

    PMID: 39329005
  35. 35

    Update on Asthma Management Guidelines.

    Dubin S, Patak P, Jung D

    Missouri medicine 2024; (121(5)):364-367.

    PMID: 39421468
  36. 36

    Cough-Variant Asthma: A Review of Clinical Characteristics, Diagnosis, and Pathophysiology.

    Cox JK, Lockey R, Cardet JC

    The journal of allergy and clinical immunology. In practice 2025; (13(3)):490-498 doi:10.1016/j.jaip.2024.11.005.

    PMID: 39557293
  37. 37

    Unraveling asthma through single-cell RNA sequencing in understanding disease mechanisms.

    Yuan X, Li C, Yang L, et al.

    The Journal of asthma : official journal of the Association for the Care of Asthma 2025; (62(8)):1257-1265 doi:10.1080/02770903.2025.2472358.

    PMID: 40014380
  38. 38

    Performance of two portable exhaled nitric oxide fraction devices compared to a "gold standard" chemiluminescence device.

    Thanikkel L, Vogt A, Micic SJ, et al.

    ERJ open research 2025; (11(2)) doi:10.1183/23120541.00751-2024.

    PMID: 40297648
  39. 39

    Comparison of oscillometry with lung function parameters between patients with stable bronchial asthma with airflow obstruction and chronic obstructive pulmonary disease.

    De S, Sarda AA

    BMC pulmonary medicine 2025; (25(1)):333 doi:10.1186/s12890-025-03754-2.

    PMID: 40640734
  40. 40

    27-Hydroxycholesterol Exacerbates the Pathogenesis of Asthma.

    Li Y, Liu X, Shang F, et al.

    Immunology 2026; (177(1)):83-93 doi:10.1111/imm.70026.

    PMID: 40787692
  41. 41

    Maintenance and Reliever Therapy in Pediatric Asthma: A Concise Review of Recent Evidence-Part I.

    Alharbi R, Alharbi AS

    Pediatric annals 2025; (54(10)):e367-e371 doi:10.3928/19382359-20250828-07.

    PMID: 41060060
  42. 42

    Predictors of depression in asthma patients in an Indian referral hospital.

    Kataria A, Daniel J, Isaac B, et al.

    PloS one 2026; (21(1)):e0338126 doi:10.1371/journal.pone.0338126.

    PMID: 41481670
  43. 43

    Integrating GPCR Regulation and Calcium Dynamics in Airway Smooth Muscle Function: A Comprehensive Review.

    Roy S, Gangipangi VK, Sharma P, et al.

    Cells 2026; (15(2)) doi:10.3390/cells15020203.

    PMID: 41597277
  44. 44

    Does asthma treatment influence COVID-19 severity? A comparative cohort study of SMART vs. Traditional therapy.

    Li Y, Chen W, Hill R, et al.

    European clinical respiratory journal 2026; (13(1)):2683007 doi:10.1080/20018525.2026.2683007.

    PMID: 42266192